Found 0 matching trials
Chemo-immunotherapy, Hypo-fractionated RT and Maintenance Immunotherapy for Stage III NSCLC.
PHASE2Aim of this phase 2 study is to evaluate the safety and the efficacy of the...
Location
Fondazione IRCCS Policlinico San Matteo
Boosting Exercise Adherence in Knee Osteoarthritis
NAThis project, conducted within the Department of Veterans Affairs Healthcar...
Location
Durham VA Medical Center, Durham, NC
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
PHASE1This clinical trial will evaluate the combination of quaratusugene ozeplasm...
Location
Rocky Mountain Cancer Centers, LLP
Peginesatide for Anemia in Chronic Hemodialysis Patients
PHASE2The purpose of this study is to evaluate the safety, pharmacodynamics (PD),...
Location
Research Facility
Safety, Tolerance and Pharmacokinetics Study of Compound Edaravone Injection
PHASE1Study on the Safety, Tolerance and Pharmacokinetics of Single-dose, Increas...
Location
Beijing Tiantan Hospital, Capital Medical University
Radiation and Combination Immunotherapy for Melanoma
PHASE2This is a Phase 2 study designed to evaluate the combination of checkpoint ...
Location
University of Minnesota Masonic Cancer Center
The Effect of Dexmedetomidine to Cognition of Geriatrics in Prolonged Surgery
PHASE4The incidence of postoperative cognitive dysfunction (POCD) is high and POC...
Location
Multiple Locations
Sequential or Up-front Triple Treatment With Durvalumab, Tremelimumab and Bevacizumab for Non-resectable Hepatocellular Carcinoma (HCC) Patients
PHASE2This is a randomized, open-label, multi-center, international, Phase II stu...
Location
Hospital of the University of Munich
Pembrolizumab + Idelalisib for Lung Cancer Study
PHASE1This is a phase 1b/2 study to determine the safety and effectiveness of the...
Location
Georgia Cancer Center at Augusta University
Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia
PHASE1This phase I trial studies the side effects and best dose of azacitidine wh...
Location
University of Chicago Comprehensive Cancer Center